Interesting ImagesMetastatic Midgut Carcinoid in the MyocardiumBukowczan, Jakub MD*; Lois, Konstantinos B. MD, PhD*; Skinner, Jane MD†; Petrides, George MD‡; James, Robert Andrew MD*; Perros, Petros MD* Author Information From the *Regional Neuroendocrine Tumour Service, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK, †Department of Cardiology, Royal Victoria Infirmary, Newcastle upon Tyne, UK, and ‡Department of Nuclear Medicine, Royal Victoria Infirmary, Newcastle upon Tyne, UK. Received for publication November 13, 2014; revision accepted May 1, 2015. Institution where work was performed: Regional Neuroendocrine Tumour Service, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK. Conflicts of interest and sources of funding: none declared. Correspondence to: Jakub Bukowczan, MD, Department of Endocrinology, Elliott Building, Royal Victoria Infirmary, Newcastle upon Tyne, NE1 4LP, UK. E-mail: [email protected]. Clinical Nuclear Medicine: September 2015 - Volume 40 - Issue 9 - p e446-e447 doi: 10.1097/RLU.0000000000000884 Buy Metrics Abstract Metastasis of neuroendocrine tumor to the myocardium is rare. We present a case of 64-year-old woman, who presented initially with abdominal pain and large adnexal mass. The image-guided biopsy showed low-grade neuroendocrine tumor with Ki67 less than 2% within the ovarian tissue. CT staging revealed bilateral adnexal masses, liver metastases, and primary lesion in the terminal ileum. Octreoscan showed marked tracer uptake within the lower esophagus not related to obvious mass on CT scan; the echocardiography confirmed the presence of a 2.7 cm LV/LA mass. In this case, close correlation between ECHO and the octreoscan obviated need for myocardial biopsy. Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.